BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 5056666)

  • 21. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat.
    Jones EA; Waldmann TA
    J Clin Invest; 1972 Nov; 51(11):2916-27. PubMed ID: 5080417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of immune precipitation by complement.
    Schifferli JA; Bartolotti SR; Peters DK
    Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The binding of myelin basic protein to the Fc region of aggregated IgG and to immune complexes.
    Sindic CJ; Cambiaso CL; Masson PL; Laterre EC
    Clin Exp Immunol; 1980 Jul; 41(1):1-7. PubMed ID: 6160001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H; Scott JG; Movat HZ; Scialla SJ
    J Lab Clin Med; 1979 Aug; 94(2):256-65. PubMed ID: 110893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of a binding reactivity of human C-reactive protein for immunoglobulin or immune complexes.
    Ballou SP; Macintyre SS
    J Lab Clin Med; 1990 Mar; 115(3):332-8. PubMed ID: 2107267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.
    Doekes G; Vanes LA; Daha MR
    Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine prekallikrein activator with functional activity as Hageman factor.
    Komiya M; Nagasawa S; Suzuki T
    J Biochem; 1972 Nov; 72(5):1205-18. PubMed ID: 4675207
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP; Gruber B; Harpel PC
    Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.
    Kessler SW
    J Immunol; 1975 Dec; 115(6):1617-24. PubMed ID: 1102604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
    Kauffmann RH; de Rooy-Dijk HH; Klein F; Lafeber GJ; Cats A; van Es LA
    Clin Exp Immunol; 1983 Oct; 54(1):203-12. PubMed ID: 6311469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG.
    Lucisano YM; Mantovani B
    J Immunol; 1984 Apr; 132(4):2015-20. PubMed ID: 6699405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).
    Morrison DC; Cochrane CG
    J Exp Med; 1974 Sep; 140(3):797-811. PubMed ID: 4378413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of various infusion media and solutions on the kallikrein-kinin system of human plasma].
    Dotsenko VL; Morozova NA; Iarovaia GA
    Vopr Med Khim; 1985; 31(4):116-21. PubMed ID: 3931350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.
    Walsh GM; Kay AB
    Clin Exp Immunol; 1986 Feb; 63(2):466-72. PubMed ID: 3698341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.
    Wahn V; Good RA; Gupta S; Pahwa S; Day NK
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():49-58. PubMed ID: 6203331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of the amplified enzyme-linked immunosorbent assay: comparative quantitation of bovine serum IgG1, IgG2, IgA, and IgM antibodies.
    Butler JE; McGivern PL; Cantarero LA; Peterson L
    Am J Vet Res; 1980 Sep; 41(9):1479-91. PubMed ID: 7004283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.